Sign up to save your podcasts
Or
Share Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial
The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths.
Read this story here.
Learn about your ad choices: dovetail.prx.org/ad-choices
View all episodes
By WIRED
4.3
5656 ratings
The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths.
Read this story here.
Learn about your ad choices: dovetail.prx.org/ad-choices
More shows like Science, Spoken
View all
The Political Scene | The New Yorker
4,001 Listeners
Making Sense with Sam Harris
26,387 Listeners
Pivot
9,483 Listeners
Uncanny Valley | WIRED
481 Listeners
What's New
100 Listeners
Business, Spoken
50 Listeners
Pod Save America
87,143 Listeners
The Daily
112,467 Listeners
Security, Spoken
60 Listeners
Ologies with Alie Ward
24,240 Listeners
Citadel Dropouts: a Game of Thrones Podcast
77 Listeners
Hard Fork
5,470 Listeners
Spark & Fire: Fuel Your Creativity
398 Listeners
Huberman Lab
29,146 Listeners
The Ezra Klein Show
16,072 Listeners
Unexplainable
2,285 Listeners
On with Kara Swisher
3,424 Listeners